Posts Tagged ‘Eli Lilly’

Why Pharma Execs Want A More Favorable Tax Climate

The idea of companies moving their businesses to other parts of the world to benefit from lower taxes is not new. Allergan, the maker of Botox® and other drugs, transferred its global headquarters from New Jersey to Ireland in 2013. Medtronic moved its headquarters to Ireland in 2015, once it completed the acquisition of Covidien, […]

[Guide] The State Of The Life Sciences Industry

Last year’s presidential election invoked a great deal of angst in the pharmaceutical industry, with the cost of drugs taking center stage for a good portion of some candidates’ campaigns. While the things candidates said they would do could very well be different from what they might actually do, their words and records were enough […]

Eli Lilly Launched 50+ Apps On Salesforce

As one of Salesforce’s strategic partners, I’m glad to share the success Eli Lilly is having with the Salesforce platform. According to a press release that was issued by Salesforce, the pharmaceutical company has launched 50+ internal and external applications over the last two years. TrialGuide is one example. The website, which is naturally mobile-friendly, […]

Top 5 Life Sciences Blog Posts From August 2016

Now that September is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in August – they’re ranked in order of popularity, with number one being the most viewed piece. Pfizer, Eli Lilly, And Roche […]

Pfizer, Eli Lilly, And Roche Speak On Using Digital Health Tools

At this year’s MedCity CONVERGE, a two-day summit in which executives convene to discuss the future of innovation in healthcare and life sciences, digital was a hot topic. In a presentation titled “Digital Health’s Arrival (Or Not) In Pharma,” Dr. Naomi Fried, an expert on digital health innovation and past chief innovation officer at Boston […]

Top 5 Life Sciences Blog Posts From April 2016

Now that May is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in April – they’re ranked in order of popularity, with number one being the most viewed piece. From Laptops To Tablets: Eli Lilly Bought […]

From Laptops To Tablets: Eli Lilly Bought 15,000 iPads

  Mwandama Mutanuka, a colleague of mine who’s involved in business process management (BPM) projects at Perficient, recently authored a blog post about how enterprise mobility can improve clinical research. He started his piece with news that highlighted Eli Lilly’s purchase of 15,000 iPads for employees, starting a few years back. Now, they’re upgrading to […]

Survey Says: Patients Like Being Involved In Clinical Trials

  Several months ago I posted Why Don’t I See Ads For Clinical Trials?, a piece in which I questioned just that. In a society where healthcare is always front and center, how is it that most of us are still unaware of our options when it comes to participating in clinical research? 

Top 5 Life Sciences Blog Posts From June 2015

  Now that July is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in June – they’re ranked in order of popularity, with number one being the most viewed piece. 

Eli Lilly Is Doing Something Interesting, Digitally Speaking

  On June, 28, 2015, CNN will be presenting Glen Campbell: I’ll Be Me, a documentary that showcases the life of the award-winning musician who struggles with Alzheimer’s. What’s unique about the film’s presentation, aside from the story itself, is that it will be complemented with three targeted commercials: a 30-second commercial, in which Eli […]

Eli Lilly CEO Breaks Down 5 Misconceptions About Pharma

  The pharma industry undoubtedly gets a bad rap. “Drug companies charge too much.” “They are only in it for themselves.” And it goes on and on. But are these accusations truly justified? In a recent Forbes opinion piece, John Lechleiter, Chairman, President, and Chief Executive Officer of Eli Lilly, brilliantly debunks the more common […]